Thursday, February 22, 2024
Home Tags Immutep

Tag: Immutep

First dose administered in Efti, BAVENCIO trial for metastatic urothelial cancer

Immutep Limited, a pioneering clinical-stage biotechnology company specializing in LAG-3 immunotherapies, announced the enrollment and safe dosing of the first patient in the INSIGHT-005 Phase I trial in the fight against metastatic urothelial carcinoma.

Immutep gets green light for large-scale cancer product manufacturing for clinical trials

Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use. 

Safe Direction

PP Shim

Wilsons Solar & Electrical

Featured Article

The Intelligent Manufacturing Forum: Automation pathways for Australian manufacturers

The Australian manufacturing sector is navigating increasingly rapid changes in industry dynamics as more technological advancements are adopted worldwide.